D
Ocular Therapeutix, Inc. OCUL
$11.87 -$0.43-3.50% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -54.91% 1.23% -65.60% -6,972.29% -111.67%
Total Depreciation and Amortization 7.32% 6.63% -0.73% 7.75% 46.63%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -26.13% -70.10% -42.16% 101.30% 228.31%
Change in Net Operating Assets -82.36% 142.52% 113.09% -119.46% 168.34%
Cash from Operations -122.72% -31.82% -75.60% -372.83% -23.55%
Capital Expenditure -67.79% -658.04% 55.99% 65.64% 62.71%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -50.27% -658.04% 55.99% 65.64% 62.71%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 4,353.83% -98.70% -95.83% 442.60% -77.23%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 4,353.83% -98.70% -95.83% -91.96% -77.23%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 277.54% -114.78% -141.19% -173.89% -87.99%